NEXAVAR IN TREATMENT OF HEPATOCELLULAR CARCINOMA
Hepatocellular carcinoma (HCC) is a significant health problem. Globally is the second most common cause of cancer-associated death and the fifth most frequent neoplasm. The main risk factors for the onset of HCC are well recognized, including the presence of cirrhosis, chronic hepatitis C and hep...
Main Authors: | Gabriela Smira, Adina Croitoru, Andra Visan, Ioana Luca, Iulia Gramaticu, Florina Buica, Ioana Dinu, Vladislav Brasoveanu, Doina Hrehoret, Irinel Popescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2018-12-01
|
Series: | Romanian Journal of Medical Practice |
Subjects: | |
Online Access: | https://revistemedicale.amaltea.ro/Romanian_Journal_of_MEDICAL_PRACTICE/Practica_medicala-2018-Nr.4/RJMP_2018_4_Art-07.pdf |
Similar Items
-
Hepatocellular carcinoma in hispanics
by: Nahum Méndez-Sánchez, et al.
Published: (2007-10-01) -
PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONS
by: V. V. Breder, et al.
Published: (2017-11-01) -
Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
by: Omar Abdel-Rahman, et al.
Published: (2014-03-01) -
IMPACT OF NON-ONCOLOGICAL AND ONCOLOGICAL FACTORS ON TUMOR RECURRENCE IN HCC LIVER TRANSPLANTED PATIENTS-SINGLE LIVER TRANSPLANT CENTRE EXPERIENCE
by: Gabriela Smira, et al.
Published: (2018-12-01) -
Clinical cases of treatment of patients with advanced hepatocellular carcinoma
by: V V Petkau, et al.
Published: (2018-03-01)